ZURICH and NESS ZIONA, Israel - NLS Pharmaceutics Ltd. (Nasdaq: NLSP) and Kadimastem Ltd. (TASE: KDST) announced plans for a merger, aiming to enhance diabetes treatment by combining their expertise ...
From hallucinations to swollen feet and an unexpected stop at a police station, former British soldier Harry Amos’s journey ...
GLP1RA mimic the GLP-1 hormone in the body that helps control insulin and blood glucose levels and promotes feelings of satiety. GLP-1 binds to GLP1R on cells in the brain and pancreas.
Diabetes is a common, lifelong condition that occurs when the pancreas doesn't produce enough insulin, or when the body is ...
Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on w ...
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Surrogate measures of insulin resistance, based on the triglyceride-glucose index, can be used to predict the development of ...
The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...
Intermittent fasting is becoming increasingly popular. But is it helpful for weight loss and other medical conditions?
Mitochondria are essential for generating energy that fuels cells and helps them function. Mitochondrial defects, however, ...
Some older people in Zimbabwe are taking up exercise wherever they can find the space as non-communicable diseases such as diabetes become a growing problem across Africa.
Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results